Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

A systematic review and meta-analysis from the Harvard T.H. Chan School of Public Health reported a large effect of ...

The patent, when formally approved, will reinforce protection for Silo’s lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The patent includes newly added ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

Adults with attention-deficit/hyperactivity disorder (ADHD) who use an extended-release medication are more likely to ...